Urinary Strong Ion Difference as a Marker of Renal Dysfunction. A Retrospective Analysis.

INTRODUCTION:The kidneys play a crucial role in the regulation of electrolytes and acid-base homeostasis. Urinary Strong Ion Difference (SIDu = NaU + KU-ClU) represents an important aspect of renal acid-base regulation. We evaluated the role of SIDu as a marker of renal dysfunction in critically ill...

Full description

Bibliographic Details
Main Authors: Paolo Balsorano, Stefano Romagnoli, Samuel Kagan Evans, Zaccaria Ricci, Angelo Raffaele De Gaudio
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4892615?pdf=render
id doaj-b81244c8d23a4838afcb63773d674979
record_format Article
spelling doaj-b81244c8d23a4838afcb63773d6749792020-11-25T01:50:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015694110.1371/journal.pone.0156941Urinary Strong Ion Difference as a Marker of Renal Dysfunction. A Retrospective Analysis.Paolo BalsoranoStefano RomagnoliSamuel Kagan EvansZaccaria RicciAngelo Raffaele De GaudioINTRODUCTION:The kidneys play a crucial role in the regulation of electrolytes and acid-base homeostasis. Urinary Strong Ion Difference (SIDu = NaU + KU-ClU) represents an important aspect of renal acid-base regulation. We evaluated the role of SIDu as a marker of renal dysfunction in critically ill patients. MATERIALS AND METHODS:Patients admitted to the Medical Intensive Care Unit with a diagnosis of AKI for whom concomitant urinary samples available for SIDu calculation were retrospectively reviewed and staged according to KDIGO criteria for 3 days from inclusion. Patients were classified as Recovered (R-AKI) or Persistent-AKI (P-AKI) whether they exited KDIGO criteria within the 3-day observation period or not. A control group with normal renal function and normal serum acid-base and electrolytes was prospectively recruited in order to identify reference SIDu values. RESULTS:One-hundred-and-forty-three patients with a diagnosis of AKI were included: 77 with R-AKI, and 66 with P-AKI. Thirty-six controls were recruited. Patients with P-AKI had more severe renal dysfunction and higher mortality than patients with R-AKI (SCr 2.23(IQR:1.68-3.45) and 1.81(IQR1.5-2.5) mg/dl respectively, p<0.001; 24-h UO 1297(950) and 2100(1094) ml respectively, p = 0.003); 30-d mortality, 39% and 13% respectively; p<0.001). SIDu significantly differed between groups, with rising values from controls to P-AKI groups (16.4(12), 30(24) and 47.3(21.5) mEq/l respectively, p<0.001). DISCUSSION:SIDu may be a simple and inexpensive tool in AKI patients' evaluation. Further research is needed to evaluate the ability of SIDu to identify patients with renal dysfunction before derangements in serum creatinine or urine output are observed.http://europepmc.org/articles/PMC4892615?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Paolo Balsorano
Stefano Romagnoli
Samuel Kagan Evans
Zaccaria Ricci
Angelo Raffaele De Gaudio
spellingShingle Paolo Balsorano
Stefano Romagnoli
Samuel Kagan Evans
Zaccaria Ricci
Angelo Raffaele De Gaudio
Urinary Strong Ion Difference as a Marker of Renal Dysfunction. A Retrospective Analysis.
PLoS ONE
author_facet Paolo Balsorano
Stefano Romagnoli
Samuel Kagan Evans
Zaccaria Ricci
Angelo Raffaele De Gaudio
author_sort Paolo Balsorano
title Urinary Strong Ion Difference as a Marker of Renal Dysfunction. A Retrospective Analysis.
title_short Urinary Strong Ion Difference as a Marker of Renal Dysfunction. A Retrospective Analysis.
title_full Urinary Strong Ion Difference as a Marker of Renal Dysfunction. A Retrospective Analysis.
title_fullStr Urinary Strong Ion Difference as a Marker of Renal Dysfunction. A Retrospective Analysis.
title_full_unstemmed Urinary Strong Ion Difference as a Marker of Renal Dysfunction. A Retrospective Analysis.
title_sort urinary strong ion difference as a marker of renal dysfunction. a retrospective analysis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description INTRODUCTION:The kidneys play a crucial role in the regulation of electrolytes and acid-base homeostasis. Urinary Strong Ion Difference (SIDu = NaU + KU-ClU) represents an important aspect of renal acid-base regulation. We evaluated the role of SIDu as a marker of renal dysfunction in critically ill patients. MATERIALS AND METHODS:Patients admitted to the Medical Intensive Care Unit with a diagnosis of AKI for whom concomitant urinary samples available for SIDu calculation were retrospectively reviewed and staged according to KDIGO criteria for 3 days from inclusion. Patients were classified as Recovered (R-AKI) or Persistent-AKI (P-AKI) whether they exited KDIGO criteria within the 3-day observation period or not. A control group with normal renal function and normal serum acid-base and electrolytes was prospectively recruited in order to identify reference SIDu values. RESULTS:One-hundred-and-forty-three patients with a diagnosis of AKI were included: 77 with R-AKI, and 66 with P-AKI. Thirty-six controls were recruited. Patients with P-AKI had more severe renal dysfunction and higher mortality than patients with R-AKI (SCr 2.23(IQR:1.68-3.45) and 1.81(IQR1.5-2.5) mg/dl respectively, p<0.001; 24-h UO 1297(950) and 2100(1094) ml respectively, p = 0.003); 30-d mortality, 39% and 13% respectively; p<0.001). SIDu significantly differed between groups, with rising values from controls to P-AKI groups (16.4(12), 30(24) and 47.3(21.5) mEq/l respectively, p<0.001). DISCUSSION:SIDu may be a simple and inexpensive tool in AKI patients' evaluation. Further research is needed to evaluate the ability of SIDu to identify patients with renal dysfunction before derangements in serum creatinine or urine output are observed.
url http://europepmc.org/articles/PMC4892615?pdf=render
work_keys_str_mv AT paolobalsorano urinarystrongiondifferenceasamarkerofrenaldysfunctionaretrospectiveanalysis
AT stefanoromagnoli urinarystrongiondifferenceasamarkerofrenaldysfunctionaretrospectiveanalysis
AT samuelkaganevans urinarystrongiondifferenceasamarkerofrenaldysfunctionaretrospectiveanalysis
AT zaccariaricci urinarystrongiondifferenceasamarkerofrenaldysfunctionaretrospectiveanalysis
AT angeloraffaeledegaudio urinarystrongiondifferenceasamarkerofrenaldysfunctionaretrospectiveanalysis
_version_ 1725001072118857728